West Pharmaceutical Services Inc. buy UBS Group AG
Start price
12.12.24
/
50%
€310.00
Target price
12.12.25
€372.22
Performance (%)
-27.03%
End price
13.12.25
€226.20
Summary
This prediction ended on 13.12.25 with a price of €226.20. The prediction for West Pharmaceutical Services Inc. disappointed with a performance of -27.03%. UBS_Group_AG has a follow-up prediction for West Pharmaceutical Services Inc. where he still thinks West Pharmaceutical Services Inc. is a Buy. A total of €0.20 was paid as dividends for this prediction. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| West Pharmaceutical Services Inc. | -5.112% | -5.112% | -27.958% |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% |
Comments by UBS_Group_AG for this prediction
In the thread West Pharmaceutical Services Inc. diskutieren
West Pharmaceutical Services, Inc. (NYSE: WST) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating. They now have a $390.00 price target on the stock, up previously from $350.00.
Ratings data for WST provided by MarketBeat
In the thread Trading West Pharmaceutical Services Inc.
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten
Current prediction by UBS_Group_AG for West Pharmaceutical Services Inc.
West Pharmaceutical Services Inc.
Start price
Target price
Perf. (%)
€226.50
25.07.25
25.07.25
€272.54
25.07.26
25.07.26
0.88%
22:26
22:26
